Beth LeBow
Lawyers
Advises issuers and financial institutions on a variety of capital markets transactions, including IPOs and other equity and debt offerings.
Beth advises issuers and underwriters on capital markets transactions, including initial public offerings and other equity offerings, private placements, and debt and convertible debt offerings. She also provides advice to clients on public reporting, securities compliance and corporate governance matters.
Beth has experience across a wide variety of industries, with a particular focus on healthcare and life sciences and on technology.
Experience
Recent Work
- Ambiq Micro $179.4 million follow-on offering
- NeoGenomics $316.25 million convertible senior notes offering
- NVIDIA $25 billion senior notes offering
- Amazon.com C$14 billion debut Canadian dollar notes offering
- Planet Labs PBC $1.5 billion at-the-market offering and forward transaction
- Immix Biopharma $150 million stock offering
- Cerebras Systems $6.4 billion IPO
- Personalis $150 million at-the-market offering
- Alector $125 million at-the-market offering
- Oruka Therapeutics $700 million follow-on offering
- Marvell Technology $1 billion senior notes offering
- CytomX Therapeutics $250 million follow-on offering
- Amazon.com €14.5 billion notes offering
- Salesforce $25 billion debt offering
- Amazon.com $37 billion notes offering
- indie Semiconductor $150 million convertible senior notes offering
News
Education
J.D., Stanford Law School
- Editor, Stanford Law Review
B.S., Animal Science, Cornell University
- summa cum laude
- with distinction in research
Qualifications and admissions
- State of California